Tamtam Try Tamtam free
Philip Morris International logo

Philip Morris International account plan

Developing smoke-free products

At a glance

Philip Morris International sells cigarettes and smoke-free products (IQOS, ZYN, VEEV): $40.6 billion 2025 net revenues, about 84,900 employees.

Philip Morris International (PMI) is a NYSE-listed tobacco and nicotine company that sells cigarettes, led by Marlboro, in approximately 170 markets and smoke-free products, mainly IQOS heat-not-burn, ZYN nicotine pouches and VEEV e-vapor, in 109 markets at June 30, 2026. Its stated goal is to completely end the sale of cigarettes. In 2025 net revenues were $40,648 million (+7.3%), operating income $14,892 million (+11.1%) and diluted EPS $7.26; smoke-free products made up 41.5% of net revenues. It had approximately 84,900 employees at December 31, 2025. Jacek Olczak is Group CEO.

Business units

Strategic priorities

Shift smokers to smoke-free products
Reallocate resources from cigarettes to smoke-free products; 2026-2028 targets call for smoke-free shipment growth of high single digits to low teens.
Re-accelerate ZYN in the U.S.
Brand building, higher-strength products (ZYN Ultra 9mg and 11mg launched in June 2026) and a "360" U.S. investment push in the second half of 2026.
Bring IQOS ILUMA to the U.S.
The IQOS ILUMA PMTA/MRTPA filed October 2023 is still pending; PMI is preparing for launch subject to FDA action.
Medium-term financial targets
2026-2028 CAGR targets: organic net revenue 6-8%, organic operating income 8-10% and currency-neutral adjusted EPS 9-11%.
Cost savings and deleveraging
Over $1.8 billion of cumulative gross cost savings toward $2 billion for 2024-2026, and adjusted leverage targeted close to 2x by end-2026 from 2.5x.

Latest results

In Q2 2026 net revenues rose 10.4% to $11,192 million (+7.6% organic), the first quarter above $11 billion, and operating income rose 22.0% to $4,530 million. Diluted EPS fell to $1.80 because of a $511 million impairment of the RBH (Canada) investment, while adjusted diluted EPS rose 15% to $2.20. International Smoke-Free shipments grew 8.0% to 44.7 billion units; Japan IQOS sales dipped after the April excise rise. 2026 guidance was kept at organic net revenue +5-7% and currency-neutral adjusted EPS +7.5-9.5%, with adjusted EPS of $8.26 to $8.41 and operating cash flow around $13.5 billion.

Investments and deals

Smoke-free manufacturing capacity
Capex was $1.6 billion in 2025, mainly smoke-free manufacturing capacity, and is guided at $1.4-1.6 billion for 2026; full-scale ZYN production began in Colorado.
U.S. commercial investment
A "When It Clicks" ZYN brand campaign, a ZYN-Ferrari global partnership and accelerated U.S. marketing, distribution and in-store investment in H2 2026.
German factory restructuring
$241 million of restructuring charges in 2025 to end combustible production in two German factories.
Divestments
Consumer accessories businesses sold or held for sale in Q4 2025, after the sale of Vectura on December 31, 2024.

Challenges and risks

Smoke-free regulation
Bans or severe restrictions in markets such as Brazil, India, Mexico and Australia, characterizing flavor bans in Poland and Hungary, the EU TPD revision and the UK generational sales ban bill adopted on April 29, 2026.
Excise taxes
Japan raised heated-tobacco excise on April 1 and October 1, 2026, and the EU Tobacco Excise Directive proposal would extend excise to smoke-free products from 2028.
Slower U.S. ZYN growth
Olczak said ZYN "is growing in The US, but it not growing at our expectations"; Q2 2026 U.S. shipments rose only 1.8%.
Russia exposure
Russia was around 6% of 2025 net revenues, and Russian operations held about $5.6 billion of assets at June 30, 2026.
Illicit trade and cigarette decline
Illicit trade is estimated at up to 15% of global cigarette consumption excluding China and the U.S., and cigarette shipments are expected to fall 2% to 3% in 2026.

What leadership says

“2025 was another outstanding year for PMI. The shift of adult smokers to better alternatives is a lasting structural movement, one that we continue to lead”

Jacek Olczak, Group CEO · Q4 and full-year 2025 earnings call, February 6, 2026

“AI is gonna be an engine for more efficiency and for cost performance in the future”

Emmanuel Babeau, Group Chief Financial Officer · Q4 and full-year 2025 earnings call, February 6, 2026

“after several quarters of frustration, it's a great moment”

Emmanuel Babeau, Group Chief Financial Officer · Q2 2026 earnings call on the U.S. step-up, July 22, 2026

“the underlying growth trend in Europe has not substantially changed”

Massimo Andolina, Regional President for Europe and CFO-designate · Q2 2026 earnings call, July 22, 2026

Where a supplier can help

U.S. go-to-market execution
The "360" U.S. investment push for ZYN and the preparation for IQOS ILUMA create demand for retail execution, trade marketing, distribution and consumer-data partners.
Cost-savings programme
The $2 billion 2024-2026 gross cost-savings target, about 60% from COGS, and the CFO's view of AI as an efficiency engine open doors for procurement, automation and AI suppliers.
Smoke-free manufacturing
Capex of $1.4-1.6 billion in 2026, mainly smoke-free capacity, and ZYN production in Colorado point to equipment, packaging and electronics manufacturing services suppliers.
Regulatory and compliance support
Pending FDA applications, the EU TPD revision and flavor bans make regulatory science, compliance and age-verification providers relevant.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Philip Morris International?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Philip Morris International

What does Philip Morris International do?

PMI sells cigarettes, led by Marlboro, in approximately 170 markets and smoke-free products such as IQOS heated tobacco, ZYN nicotine pouches and VEEV e-vapor, with the stated goal of ending cigarette sales.

What is Philip Morris International's revenue?

Net revenues were $40,648 million in 2025, up 7.3%, with 41.5% from smoke-free products. H1 2026 net revenues were $21,338 million.

How many employees does Philip Morris International have?

Approximately 84,900 people worldwide at December 31, 2025.

Who leads Philip Morris International?

Jacek Olczak is Group CEO. Massimo Andolina became Group CFO in August 2026, succeeding Emmanuel Babeau; Frederic de Wilde runs PMI International and Stacey Kennedy PMI U.S.

What is PMI's strategy?

Move adult smokers to smoke-free products while keeping its cigarette position through selective investment, targeting organic net revenue growth of 6-8% a year over 2026-2028.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)